Q4 results financial results - Clariant
Q4 results financial results - Clariant
Q4 results financial results - Clariant
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Quarterly Report<br />
February 17, 2009<br />
Contents Page<br />
News Release 1<br />
Financial Discussion 3<br />
Business Discussion 5<br />
Condensed Financial Statement (unaudited) 10<br />
www.clariant.com<br />
<strong>Clariant</strong> International Ltd<br />
Rothausstrasse 61<br />
CH-4132 Muttenz 1, Switzerland<br />
quarterly report<br />
CONSOLIDATED FINANCIAL STATEMENTS<br />
OF THE CLARIANT GROUP<br />
1
quarterly report<br />
NEwS RELEASE<br />
<strong>Clariant</strong> improves operational performanCe and strengthens foCus on Cash<br />
generation and Cost reduCtion<br />
Sales of CHF 8.1 billion in 2008, up 1% in local currencies<br />
– Price increase of 7% compensates for a 15% increase in raw material costs<br />
– Volume erosion in most businesses in <strong>Q4</strong><br />
Operating income margin before exceptionals up to 6.6% from 6.3% in 2007<br />
– SG&A costs down to 20.3% from 20.8% of sales<br />
Net loss of CHF 37 million due to CHF 180 million impairment in Textile and Leather Businesses<br />
Operating cash flow at CHF 391 million<br />
Net debt reduced to CHF 1.21 billion from CHF 1.36 billion; solid maturity profile<br />
Outlook: <strong>Clariant</strong> addresses challenging economic environment by further restructuring and focusing on cash<br />
generation and cost reduction<br />
Ceo hariolf Kottmann commented: “our company achieved an improved operating margin and a solid cash flow from<br />
operations in 2008 against the backdrop of a steep decline in demand in the last quarter. We will adjust for declining<br />
demand in our markets. at the same time we need to accelerate our restructuring efforts in order to catch up with our<br />
competitors. on the foundation of a sustainable operational performance we will manage the company for profitable<br />
growth in 2011 and beyond.”<br />
Full Year Fourth Quarter<br />
Continuing operations: 2008 2007 2008 2007<br />
CHF mn % of sales CHF mn % of sales CHF mn % of sales CHF mn % of sales<br />
Sales 8 071 100.0 8 533 100.0 1 744 100.0 2 086 100.0<br />
local currency growth (lC): 1% –9%<br />
Organic growth 1 1% –9%<br />
Acquisitions/Divestitures 0% 0%<br />
Currencies –6% –7%<br />
Gross profit 2 314 28.7 2 488 29.2 440 25.2 580 27.8<br />
eBItDa before exceptionals 783 9.7 812 9.5 104 6.0 194 9.3<br />
eBItDa* 691 8.6 628 7.4 102 5.8 90 4.3<br />
operating income before exceptionals* 530 6.6 539 6.3 42 2.4 122 5.8<br />
operating income / loss 229 2.8 278 3.3 –148 8.5 7 0.3<br />
Net loss / income from continuing operations –28 0.3 108 1.3 –199 11.4 –21 1.0<br />
Net loss / income –37 0.5 5 0.1 –207 11.9 –17 0.8<br />
operating cash flow (total operations) 391 540 217 220<br />
Discontinued operations:<br />
Sales 0 82 0 1<br />
Net loss from discontinued operations –9 –103 –8 4<br />
Other key figures: 31.12.2008 31.12.2007<br />
Net debt 1 209 1 361<br />
equity (including minorities) 1 987 2 372<br />
Gearing 61% 57%<br />
return on invested capital (roIC)** 9.0% 7.8%<br />
Number of employees 20 102 20 931<br />
1 throughout this statement the term “organic growth” is being used. It means volume and price effects excluding the impacts of changes in FX rates and acquisitions/divestitures.<br />
* See Definitions of terms of Financial Measurement on page 9.<br />
** <strong>Clariant</strong> calculates roIC by dividing Noplat before exceptional items by the average net capital employed. Noplat is calculated by taking the operating income before exceptional<br />
items adjusted by the expected tax rate. Net capital employed also considers operating cash and capitalized operating leases.<br />
1
Muttenz, February 17, 2009 – <strong>Clariant</strong>, a world leader in specialty<br />
chemicals, today announced sales of CHF 8.1 billion for the Full<br />
Year 2008 compared to CHF 8.5 billion in 2007. This translates into<br />
a 1% growth in local currency and a 5% decline in CHF.<br />
<strong>Clariant</strong> went through two distinct phases during fiscal year 2008. In the<br />
first nine months, the company continued to benefit from a stable demand<br />
and could cope with rising raw material costs and adverse currency<br />
movements by substantially increasing sales prices. In the fourth quarter,<br />
<strong>Clariant</strong> was significantly impacted by an unprecedented decline in global<br />
economic activity that led to a weaker demand from customer industries<br />
such as textile, leather, automotive and construction. other markets such<br />
as agrochemicals, oil services or de-icing showed resilience against the<br />
downturn. <strong>Clariant</strong> countered the unfavorable demand development in q4<br />
by reducing temporary employees and overtime as well as extended plant<br />
shutdowns over Christmas.<br />
the company could offset a 15% increase in raw materials costs in 2008<br />
by sales price increases of 7%. Due to low capacity utilization in the fourth<br />
quarter the gross margin was slightly down to 28.7% from last year’s<br />
29.2%. owing to <strong>Clariant</strong>’s strong focus on SG&a costs reduction, the<br />
operating margin before exceptional items improved to 6.6% from 6.3%<br />
in the previous year. the operating income before exceptionals reached<br />
CHF 530 million compared to CHF 539 million in 2007.<br />
as a result of the deterioration of the leather and textile markets and their<br />
uncertain evolution in 2009, <strong>Clariant</strong> revised the business plans for these<br />
two businesses, which led to an impairment of CHF 180 million.<br />
By the end of 2008, <strong>Clariant</strong> had reduced roughly 1,650 job positions out<br />
of the reduction target of approximately 2,200 that was announced in<br />
2006. the activities to reduce SG&a costs as well as the production site<br />
closures that were announced previously – namely in Horsforth, Coventry,<br />
Selby and Naucalpan – proceeded as planned. restructuring and impairment<br />
costs related to those activities amounted to CHF 141 million. total<br />
restructuring and impairment costs were at CHF 321 million. the group<br />
recorded a net loss of CHF 37 million.<br />
the operating cash flow remained solid in 2008 and reached CHF 391<br />
million despite a negative impact from inventories build-up in the first<br />
nine months. this compares to an operating cash flow of CHF 540 million<br />
in the previous year.<br />
the balance sheet of the company remains solid. <strong>Clariant</strong> was able to<br />
reduce its net debt by 11% to CHF 1.21 billion from CHF 1.36 billion. the<br />
interest expenses also developed favorably, falling to CHF 85 million from<br />
CHF 107 million in 2007. the company will not face maturities in capital<br />
markets for almost three years as all mid- and long-term debt was refinanced<br />
under favorable conditions between april 2006 and July 2008.<br />
therefore the liquidity of the <strong>Clariant</strong> group is strong and the company is<br />
prepared for a potential further economic downturn.<br />
outlook<br />
quarterly report<br />
NEwS RELEASE<br />
Currently there is no evidence that the global economy will recover soon<br />
from the depressed levels seen in recent months. However, a differentiated<br />
development among <strong>Clariant</strong>’s market segments as already observed<br />
in 2008 can be expected as parts of the company’s portfolio are less<br />
exposed to economical developments than others.<br />
In this challenging environment <strong>Clariant</strong> will accelerate several actions<br />
to address both the unsatisfactory performance and the economic slowdown.<br />
Cash generation through significantly decreasing Net Working<br />
Capital and spending discipline will be the prevailing priority for 2009 in<br />
order to create the <strong>financial</strong> headroom for decisive restructuring.<br />
Following this approach, <strong>Clariant</strong> will rapidly and forcefully implement the<br />
announced significant decrease in personnel costs by reducing thousand<br />
job positions in addition to the 2,200 announced in 2006. also, <strong>Clariant</strong><br />
will simplify its organization in order to unwind additional cash generation<br />
and cost savings potential – in particular in the SG&a area. restructuring<br />
costs in 2009 will amount to approximately CHF 200–300 million.<br />
reflecting the current uncertainties in the economic environment, the<br />
Board of Directors will recommend to <strong>Clariant</strong>’s 14th General assembly on<br />
april 2 to suspend dividends, grants or payouts to shareholders for 2008.<br />
For 2010, <strong>Clariant</strong> confirms its target of an above industry average return<br />
on Invested Capital (roIC).<br />
2
finanCial disCussion fourth Quarter<br />
Economic Environment<br />
the economic environment for the chemicals industry has worsened dramatically<br />
during the fourth quarter as a result of the global <strong>financial</strong> crisis.<br />
the full magnitude of the crisis became evident during the quarter, resulting<br />
in a steep decline in demand. Despite substantial <strong>financial</strong> stimulus<br />
packages almost all industrialized countries in the Western world fell into<br />
a recession. While emerging markets economies held up relatively well,<br />
their GDp growth has clearly fallen below potential.<br />
the economic downturn has lowered the demand for most hard commodities.<br />
the prices of these goods collapsed and currently there are no signs<br />
of a sustainable recovery in the near future.<br />
the uS dollar continued to recover against other important currencies<br />
in the first two months of the fourth quarter but devalued significantly<br />
towards year-end. on a year-on-year basis, the average exchange rates of<br />
the uS dollar and the euro were weaker against the Swiss franc.<br />
Sales and Operating Results<br />
Consolidated sales from continuing operations decreased by 16%<br />
in Swiss francs and by 9% in local currency terms. all divisions and businesses<br />
managed to increase sales prices again.<br />
the gross margin was affected by higher idle facility costs caused by<br />
the decline in sales. It decreased to 25.2% in the fourth quarter compared<br />
with 27.8% in the same period a year earlier. a 14% rise in raw material<br />
costs and higher energy costs could be successfully compensated by price<br />
increases. this also helped to mitigate the negative effect of lower sales<br />
volumes on the gross margin.<br />
Marketing, distribution, administration and general overhead<br />
costs accounted for 20.7% of sales compared to 20.2% recorded in the<br />
fourth quarter of 2007. the unfavorable development in percentage of<br />
sales was due to a lower sales figure. In absolute terms, SG&a costs fell<br />
CHF 59 million year-on-year as a result of cost reductions and favorable<br />
foreign exchange rate developments.<br />
Research and development costs of CHF 45 million in the fourth<br />
quarter of 2008 were CHF 8 million below the level recorded in the same<br />
quarter of 2007.<br />
Income from associates decreased to CHF 9 million in the fourth quarter<br />
of 2008. this compares to CHF 16 million in the corresponding period<br />
of the previous year.<br />
quarterly report<br />
FINANCIAL DISCUSSION<br />
Restructuring costs and impairments in the amount of CHF 208 million<br />
includes a CHF 180 million impairment of goodwill and fixed assets<br />
positions in the textiles and leather businesses. additional restructuring<br />
charges were booked in Germany, the united States, Switzerland, India<br />
and Spain.<br />
Net <strong>financial</strong> expenses in the fourth quarter of 2008 fell to CHF –40<br />
million, a drop of CHF –31 million compared with the prior-year period.<br />
this was entirely due to foreign exchange rate losses of CHF 18 million<br />
in the fourth quarter of 2008 compared with foreign exchange rate gains<br />
of CHF 12 million in the previous year. the weakening of all major currencies<br />
against the Swiss franc in the fourth quarter of 2008 has led to<br />
substantial unrealized valuation losses of especially intra-Group financing<br />
positions and operation positions. the net <strong>financial</strong> result before foreign<br />
exchange rate effects is the same in both periods arising from lower interest<br />
expenses through an optimized mix of net debt positions throughout<br />
the last quarters on the one hand and lower average liquidity on the other<br />
hand.<br />
Tax expenses in the fourth quarter of 2008 were negatively influenced<br />
by a non tax-effective goodwill write-off, impairment and restructuring<br />
costs that were only partly tax effective, non tax-effective idle cost and<br />
non tax-effective foreign exchange losses. In turn untaxed profits had a<br />
positive effect on the tax rate.<br />
Net loss from continuing operations amounted to CHF 199 million in<br />
the fourth quarter of 2008. this compares with a loss of CHF 21 million<br />
reported in the same period of 2007. the main reason for this variance<br />
was the unfavorable operating income development, the negative foreign<br />
exchange result as well as the higher restructuring and impairment<br />
charges.<br />
Net loss from discontinued operations amounted to CHF 8 million and<br />
was mainly related to the write-down of a vendor note and to a settlement,<br />
both made in connection with the disposal of the pharmaceutical<br />
intermediates business in 2006.<br />
3
Balance Sheet Key Figures<br />
Total assets decreased to CHF 5.946 billion as of December 31, 2008<br />
from CHF 7.285 billion at the end of 2007. the repayment of <strong>financial</strong><br />
debts, a strong increase in the exchange rate of the Swiss franc and an<br />
impairment charge in the amount of CHF 180 million contributed to this<br />
effect.<br />
Cash and cash equivalents decreased to CHF 356 million as of December<br />
31, 2008 from CHF 509 million at the end of 2007. this was the result<br />
of a reduction of <strong>financial</strong> liabilities and improved net working capital<br />
management in the fourth quarter.<br />
Current <strong>financial</strong> debt decreased to CHF 268 million as of December 31,<br />
2008 from CHF 728 million at the end of 2007, whereas non-current <strong>financial</strong><br />
debt increased to CHF 1.297 billion as of December 31, 2008 from CHF<br />
1.267 billion at the end of 2007. the former is the result of the payback of<br />
a bond in the amount of CHF 384 million in March 2008, while the latter is<br />
the net effect of both the issuance of a certificate of indebtedness in the<br />
amount of eur 100 million and foreign exchange rate differences.<br />
Equity decreased to CHF 1.987 billion as of December 31, 2008 from CHF<br />
2.372 billion at the end of 2007. this was the net effect of a net loss of<br />
CHF 37 million during the reporting period, a negative development of<br />
foreign exchange rates and a capital reduction of CHF 58 million.<br />
Net debt decreased to CHF 1.209 billion as of December 31, 2008 from<br />
CHF 1.361 billion at the end of 2007 as a result of the changes described<br />
above.<br />
Gearing, which reflects net <strong>financial</strong> debt in relation to equity including<br />
minorities, increased to 61% as of December 31, 2008 from 57% at the<br />
end of 2007.<br />
Cash Flow<br />
quarterly report<br />
FINANCIAL DISCUSSION<br />
Cash flow from operating activities before changes in working capital<br />
stood at CHF 89 million for the fourth quarter of 2008. this compares to<br />
CHF 66 million in the fourth quarter of 2007.<br />
Working capital decreased by CHF 128 million during the fourth quarter<br />
of 2008, mainly driven by lower trade receivables and lower inventories.<br />
the decrease compares to a decrease of CHF 154 million in the fourth<br />
quarter of 2007.<br />
Cash flow from operating activities stood at CHF 217 million in the<br />
fourth quarter of 2008, compared to CHF 220 million in the fourth quarter<br />
of 2007.<br />
Capital expenditure (PPE) stood at CHF 93 million for the fourth quarter<br />
of 2008, compared to CHF 101 million in the fourth quarter of 2007.<br />
4
Business disCussion fourth Quarter<br />
Textile, Leather & Paper Chemicals<br />
poor demand in all three businesses<br />
Sales in the textile, leather & paper Chemicals Division fell 13% in local<br />
currencies and 22% in Swiss francs. all three businesses have been severely<br />
impacted by falling demand in many of their end markets, especially<br />
towards the end of the quarter. Customers along the value chain have<br />
started to aggressively reduce their inventories. this in turn added to an<br />
already depressed demand situation in all world regions. as a result of the<br />
deterioration of the leather and textile markets and their uncertain evolution<br />
in 2009, <strong>Clariant</strong> revised the business plans for these two businesses,<br />
which led to an impairment of CHF 180 million. the paper Business held<br />
up relatively well in the third quarter compared to textile and leather. In<br />
the fourth quarter, however, volumes dropped in the same range as for<br />
the two other businesses.<br />
gross margin deteriorating<br />
Substantially higher prices compensated higher raw material costs, but<br />
due to higher idle facility costs the gross margin was weaker compared to<br />
the same quarter 2007. to dampen the gross margin erosion, the division<br />
took several urgent measures such as the immediate alignment of production<br />
to demand and a further optimization of production costs. In addition,<br />
the division continued to massively reduce its cost basis. Despite these<br />
efforts, the operating margin turned negative in one of the worst market<br />
environments the industry has seen in decades.<br />
significant capacity reductions achieved<br />
In the fourth quarter the businesses introduced temporary capacity reductions<br />
and other short-term measures to counter the downturn in demand.<br />
additionally, to structurally adapt to changing markets, textile, leather<br />
& paper had already decided in 2007 to downsize the production capacities.<br />
accordingly the Selby site has been closed as scheduled by the end<br />
of 2008, while closing another plant in the uK in Horsforth is on track to<br />
be completed by the middle of the year. the production of chemicals not<br />
being eliminated from the product portfolio has been successfully transferred<br />
to other sites.<br />
quarterly report<br />
bUSINESS DISCUSSION<br />
Full Year Fourth Quarter<br />
2008 2007 2008 2007<br />
CHF mn % of sales CHF mn % of sales % CHF % LC CHF mn % of sales CHF mn % of sales % CHF % LC<br />
Sales 2 020 2 332 –13 –6 429 553 –22 –13<br />
eBItDa before exceptionals 152 7.5 217 9.3 –30 –22 11 2.6 52 9.4 –79 –73<br />
operating income before exceptionals 87 4.3 145 6.2 –40 –30 –5 – 34 6.1 – –<br />
operating income –131 – 40 1.7 – – –189 – 25 4.5 – –<br />
See Definitions of terms of Financial Measurements on page 9.<br />
globalization of the crisis in textiles and leather<br />
With the exception of some smaller, less important textile and leather<br />
markets, most countries experienced a double-digit sales volume contraction<br />
in the fourth quarter compared to the same period a year earlier.<br />
the development in the fourth quarter is a continuation of the negative<br />
overall trend already observed during the first nine months of 2008. the<br />
weakness in textiles and leather demand has spread from the Western<br />
world to the emerging markets, with increasing speed towards the end of<br />
the quarter. export-oriented markets in asia and latin america suffered<br />
the most from the industrialized world entering into recession. Besides<br />
spreading into all world regions, the crisis also hit businesses that had<br />
been relatively stable thus far such as footwear or leather fashion. these<br />
customer-oriented markets also started to feel the repercussions of the<br />
global <strong>financial</strong> crisis.<br />
relatively stable performance in paper<br />
the business unit paper was able to compensate the still rising raw material<br />
prices with higher sales prices. While North america and latin america<br />
achieved a robust sales growth in local currencies, europe and asia<br />
were significantly weaker year-on-year. Sales in Swiss francs have been<br />
negatively impacted by a sharp devaluation of the currencies of some<br />
important emerging markets. In asia, Indonesia stood out with sales in<br />
local currency more than doubling, reflecting its lower dependence on<br />
exports and some new contracts signed. the tight raw material situation<br />
of the last few quarters in optical brighteners has improved in that<br />
specific product line.<br />
5
Pigments & Additives<br />
destocking overshadows operational progress<br />
the slowdown already observed in the third quarter of 2008 accelerated<br />
into the fourth quarter. Sales fell 20% in local currencies and 24% in<br />
Swiss francs. the division suffered from a combination of rapidly deteriorating<br />
market conditions in some of its end markets and pronounced<br />
destocking activities along the value chain. the demand from convertors<br />
such as masterbatches producers, compounders or processors was heavily<br />
impacted by the economic downturn. Sales volumes in latin america<br />
held up well compared to the other regions despite negative local currencies<br />
sales growth. all other regions suffered from double-digit sales<br />
declines on a year-on-year basis.<br />
further cost reductions achieved<br />
the underutilization of production assets resulted in a gross margin that<br />
was roughly two percentage points lower compared to the fourth quarter<br />
2007. a further significant reduction in costs helped to limit the negative<br />
impact on the operating margin to around one percentage point compared<br />
to the fourth quarter 2008.<br />
dick peters B.v. sold to altana<br />
to streamline its portfolio, <strong>Clariant</strong> sold its Netherlands-based wax emulsions<br />
business Dick peters B.V. to the German specialty chemical group<br />
altana. the transaction worth eur 18 million was announced in November<br />
2008.<br />
quarterly report<br />
bUSINESS DISCUSSION<br />
Full Year Fourth Quarter<br />
2008 2007 2008 2007<br />
CHF mn % of sales CHF mn % of sales % CHF % LC CHF mn % of sales CHF mn % of sales % CHF % LC<br />
Sales 1 948 2 076 –6 0 370 490 –24 –20<br />
eBItDa before exceptionals 293 15.0 278 13.4 5 12 46 12.4 67 13.7 –31 –27<br />
operating income before exceptionals 216 11.1 192 9.2 13 20 27 7.3 41 8.4 –34 –30<br />
operating income 198 10.2 77 3.7 157 172 31 8.4 –48 – – –<br />
See Definitions of terms of Financial Measurements on page 9.<br />
demand erosion in the Coatings Business<br />
as a result of the abrupt halt in car production and a lower activity in<br />
the housing market, the Coatings Business was very weak in the fourth<br />
quarter. Sales volumes declined in the double-digit percentage range in<br />
all regions, except in eastern europe and some emerging markets such as<br />
India and Mexico. In these countries, volume growth and sales growth<br />
in local currencies were above the prior year period. China, one of the<br />
growth drivers in the third quarter, could not escape from the impact of<br />
the recessionary developments in many other markets.<br />
market-driven reorganization of plastics Business<br />
after showing good resilience to the slowing global economic growth<br />
in the first half of 2008, the plastics Business confirmed the downward<br />
trend that started in the third quarter. Similar to the Coatings Business,<br />
sales in the plastics Business were heavily impacted by rapidly deteriorating<br />
market conditions. to optimize the cost base and to align the structure<br />
to the customer’s needs, the division reacted by adjusting its structure<br />
and reorganizing the business. the Waxes Business was integrated into<br />
the business unit Base products as of January 1, 2009. Base products<br />
is successfully managing commoditized businesses such as printing inks<br />
and polymer additives. all other remaining products and activities will be<br />
transferred to the business unit Specialties.<br />
price increases in specialties and Base products<br />
the Specialties Business saw a sharp drop in demand for its products<br />
supplied to all kinds of specialized industries. Substantially higher sales<br />
prices could by far not compensate a double-digit volume decline. In this<br />
difficult environment Japan stood out with a strong sales growth in local<br />
currency. In the Base products Business, Germany and some smaller<br />
markets in latin america achieved robust sales growth.<br />
6
Masterbatches<br />
steep volume decline towards the end of the year<br />
Masterbatches saw its sales falling 11% in local currencies and 18%<br />
in Swiss francs in the fourth quarter. the slowdown that started in the<br />
united States in 2007 has finally spread to all other world regions. While<br />
business conditions were reasonable in the first part of the quarter, demand<br />
slowed down towards the end of the year. Many of the division’s<br />
end markets were heavily impacted by the consequences of the <strong>financial</strong><br />
crisis. Customers in these markets, namely in automotive-, construction-<br />
and consumer goods-related industries, stopped or delayed orders.<br />
packaging applications remained slightly more resilient to the global<br />
downturn. However, this was not enough to compensate the depressed<br />
demand in the other industries. additionally, destocking along the value<br />
chain exacerbated the difficult situation arising from collapsing demand.<br />
Masterbatches reacted quickly to the changing market conditions by<br />
implementing short-time work, reduction of its temporary workforce or<br />
extended production plant shut-downs.<br />
pressure on margins continued<br />
temporary production suspensions resulted in lower capacity utilization<br />
rates. accordingly, the gross margin dropped compared to the fourth quarter<br />
of 2007. the division needed to selectively adapt its sales prices to<br />
compensate for the changing raw material costs. additional cost-cutting<br />
measures helped the division to breakeven in the last three months of<br />
2008.<br />
positive contribution from the us acquisitions<br />
the combined companies of rite Systems, Inc. and ricon Colors, Inc. have<br />
been fully integrated into <strong>Clariant</strong>. their higher exposure to the more resilient<br />
packaging end markets resulted in a satisfactory performance in<br />
the fourth quarter.<br />
production started successfully in new China plant<br />
In December, <strong>Clariant</strong> opened its new production plant in Guangzhou,<br />
China, where it produces color and additive masterbatches for the rapidly<br />
growing local markets. With 14000 square meters, Guangzhou is the<br />
largest of the three Masterbatches sites in the country. the new facility<br />
is close to major customers in the pearl river delta region, which also includes<br />
Hong Kong and Macao. other strategically less important projects<br />
have been postponed due to the unfavorable global demand situation.<br />
volumes down in most european and north american<br />
markets<br />
the united States, Canada and most european markets were weak in the<br />
fourth quarter. local currency sales growth was lower in almost every<br />
developed country. the regions suffered from the complete and sudden<br />
production stop, especially in the important automotive industry. this resulted<br />
in a double-digit percentage decline in sales.<br />
.<br />
sales growth in latin america despite lower volumes<br />
although the business in latin american was not immune to the weakening<br />
global economy, the region showed robust local currency sales<br />
growth. Domestic demand in Brazil and some smaller countries remained<br />
solid compared to other world regions. Sales prices have been increased<br />
where necessary to compensate higher raw material costs.<br />
asia weak with some exceptions<br />
quarterly report<br />
bUSINESS DISCUSSION<br />
Full Year Fourth Quarter<br />
2008 2007 2008 2007<br />
CHF mn % of sales CHF mn % of sales % CHF % LC CHF mn % of sales CHF mn % of sales % CHF % LC<br />
Sales 1 278 1 380 –7 –1 258 315 –18 –11<br />
eBItDa before exceptionals 122 9.5 153 11.1 –20 –14 8 3.1 32 10.2 –75 –67<br />
operating income before exceptionals 89 7.0 124 9.0 –28 –22 0 0.0 28 8.9 – –96<br />
operating income 76 5.9 102 7.4 –25 –19 0 0.0 25 7.9 – –98<br />
See Definitions of terms of Financial Measurements on page 9.<br />
Similar to the other regions, asia had a weak fourth quarter with falling<br />
sales volumes. Despite this unfavorable development, the division was<br />
able to selectively adapt sales prices. In contrast to the general downward<br />
trend, some countries with strong local economies such as Indonesia,<br />
New Zealand and Saudi arabia continued to grow.<br />
7
Functional Chemicals<br />
resilience in functional Chemicals<br />
Sales in the Functional Chemicals Division grew 3% in local currencies<br />
due to a robust demand in many businesses. unfavorable currency developments<br />
led to a sales contraction of 6% in Swiss francs. the sales development<br />
pattern was differentiated within the division. Demand remained<br />
robust in less cyclical businesses. <strong>Clariant</strong> oil Services, personal Care,<br />
Industrial & Home Care, Crop protection and Detergents & Intermediates<br />
showed a good resilience against the evolving recession in many parts of<br />
the world. In contrast, our businesses in the coatings, construction and<br />
metal working areas were heavily impacted by the slowing demand in<br />
their respective end markets.<br />
effective margin management<br />
as a result of higher sales prices that compensated for lower volumes<br />
and higher raw material costs, the gross margin could be defended compared<br />
to the fourth quarter 2007. once more the division was successful<br />
in reducing its cost base, thereby achieving a higher operating margin<br />
compared to the previous-year period.<br />
Cracker shutdown with expected impact<br />
as announced in the third quarter, the third-party cracker supplying ethylene<br />
to <strong>Clariant</strong>’s operations in Gendorf, Germany, was temporarily shut<br />
down during the fourth quarter. although the shutdown was longer than<br />
originally planned, the division managed to source enough ethylene from<br />
other suppliers. all orders from customers have been filled in a timely<br />
manner. the <strong>financial</strong> impact of the outage on the operational result was<br />
within expectations.<br />
oil production still going strong<br />
With the opening of its new headquarters in Houston, texas, the Chemicals<br />
Management Solutions Business strengthened its position in the<br />
important North american oil and gas market. With latin america being<br />
the fastest growing market, sales in local currencies experienced doubledigit<br />
growth in all regions. Several new contracts around the globe helped<br />
to mitigate the negative impact from deferred or cancelled oil sands exploration<br />
projects and from shutdowns of production platforms in the Gulf<br />
of Mexico due to hurricane damages. Mining Services also grew significantly<br />
year-on-year although it was impacted late in the fourth quarter<br />
as a consequence of collapsing commodity prices resulting in a slightly<br />
weaker demand for products and services.<br />
record season for de-icing<br />
quarterly report<br />
bUSINESS DISCUSSION<br />
Full Year Fourth Quarter<br />
2008 2007 2008 2007<br />
CHF mn % of sales CHF mn % of sales % CHF % LC CHF mn % of sales CHF mn % of sales % CHF % LC<br />
Sales 2 825 2 745 3 9 687 728 –6 3<br />
eBItDa before exceptionals 316 11.2 262 9.5 21 28 80 11.6 78 10.7 3 12<br />
operating income before exceptionals 249 8.8 194 7.1 28 37 64 9.3 61 8.4 5 14<br />
operating income 236 8.4 194 7.1 22 30 59 8.6 60 8.2 –2 7<br />
See Definitions of terms of Financial Measurements on page 9.<br />
Market share gains resulting from successful investments and further<br />
price increases across the product portfolio helped the Industrial & Consumer<br />
Care Business to grow its sales in local currencies. Demand in the<br />
personal Care, Industrial & Home Care and Crop protection businesses<br />
remained solid. De-icing recorded strong sales growth due to the early<br />
start of the winter season. Cold and wet weather in both North america<br />
and europe led to a record quarter for the business. the construction of<br />
the strategically important new multipurpose plant in China is proceeding<br />
as planned. the plant will mainly produce chemicals for the personal<br />
Care, Metal Working and Coatings businesses and is scheduled to go into<br />
operation in summer 2009.<br />
detergents & intermediates robust<br />
the demand for laundry detergents and household cleaning products<br />
in europe – where ninety percent of the business sales are generated –<br />
remained solid despite the reduced economic activity. For the fourth quarter<br />
in a row, the Detergents & Intermediates Business exhibited profitable<br />
growth. the stringent implementation of the new business model<br />
introduced in early 2008 helped to raise the profitability to the expected<br />
level.<br />
8
definition of terms of finanCial measurements (unaudited)<br />
the following <strong>financial</strong> measurements are supplementary <strong>financial</strong> indicators.<br />
they should be considered in addition to, not as a substitute for,<br />
operating income, net income, operating cash flow and other measures of<br />
<strong>financial</strong> performance and liquidity reported in accordance with International<br />
Financial reporting Standards (IFrS).<br />
EBITDA (continuing)<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
EBITDA<br />
– (earnings Before Interest, taxes, Depreciation and amortization) is calculated<br />
as operating income plus depreciation of ppe, plus impairment of<br />
ppe/goodwill and amortization of intangibles and can be reconciled from<br />
the Condensed Financial Statements as follows:<br />
9<br />
Full Year Fourth Quarter<br />
CHF mn 2008 2007 2008 2007<br />
operating income 229 278 –148 7<br />
+ Depreciation of ppe 244 264 60 68<br />
+ Impairment of ppe / Goodwill 209 77 188 11<br />
+ amortization of other intangibles 9 9 2 4<br />
EBITDA 691 628 102 90<br />
EBITDA before exceptional items<br />
– is calculated as eBItDa plus expenses for restructuring and impairment less impairment of ppe/goodwill and gain/loss on disposals.<br />
EBITDA before exceptionals (continuing)<br />
Full Year Fourth Quarter<br />
CHF mn 2008 2007 2008 2007<br />
eBItDa 691 628 102 90<br />
+ restructuring and impairment 321 262 208 113<br />
– Impairment of ppe / Goodwill –209 –77 –188 –11<br />
(reported under restructuring and impairment)<br />
– Gain on disposals of subsidiaries and associates –20 –1 –18 2<br />
EBITDA before exceptionals 783 812 104 194<br />
Operating income before exceptional items<br />
– is calculated as operating income plus restructuring and impairment and gain/loss on disposals<br />
Operating income before exceptionals (continuing)<br />
Full Year Fourth Quarter<br />
CHF mn 2008 2007 2008 2007<br />
operating income 229 278 –148 7<br />
+ restructuring and impairment 321 262 208 113<br />
– Gain on disposals of subsidiaries and associates –20 –1 –18 2<br />
Operating income before exceptionals 530 539 42 122<br />
Net debt<br />
– is the sum of current and non-current <strong>financial</strong> debt less cash and cash equivalents and current deposits reported in other current assets.<br />
Net Debt<br />
CHF mn 31.12.2008 31.12.2007<br />
Non-current <strong>financial</strong> debt 1 297 1 267<br />
+ Current <strong>financial</strong> debt 268 728<br />
– Cash and cash equivalents –356 –509<br />
– Current deposits 90 to 365 days 0 –125<br />
Net Debt 1 209 1 361
Condensed finanCial statements of the <strong>Clariant</strong> group<br />
Consolidated balance sheets (unaudited)<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
ASSETS 31.12.2008 31.12.2007<br />
Non-current assets<br />
10<br />
CHF mn % CHF mn %<br />
property, plant and equipment 2 010 2 401<br />
Intangible assets 283 339<br />
Investments in associates 275 294<br />
Financial assets 21 17<br />
prepaid pension assets 119 122<br />
Deferred income tax assets 67 113<br />
Total non-current assets 2 775 46.7 3 286 45.1<br />
Current assets<br />
Inventories 1 373 1 477<br />
trade receivables 1 110 1 449<br />
other current assets 1 300 535<br />
Cash and cash equivalents 356 509<br />
Current income tax receivables 32 29<br />
Total current assets 3 171 53.3 3 999 54.9<br />
Total assets 5 946 100.0 7 285 100.0<br />
EQUITY AND LIABILITIES 31.12.2008 31.12.2007<br />
Equity<br />
CHF mn % CHF mn %<br />
Share capital 921 978<br />
treasury shares (par value) –15 –16<br />
other reserves 364 642<br />
retained earnings 667 709<br />
Total capital and reserves attributable to <strong>Clariant</strong> shareholders 1 937 2 313<br />
Minority interests 50 59<br />
Total equity 1 987 33.4 2 372 32.6<br />
Liabilities<br />
Non-current liabilities<br />
Financial debts 1 297 1 267<br />
Deferred income tax liabilities 134 179<br />
retirement benefit obligations 478 515<br />
provision for non-current liabilities 191 231<br />
Total non-current liabilities 2 100 35.3 2 192 30.0<br />
Current liabilities<br />
trade payables 1 011 1 321<br />
Financial debts 268 728<br />
Current income tax liabilities 243 244<br />
provision for current liabilities 337 428<br />
Total current liabilities 1 859 31.3 2 721 37.4<br />
Total liabilities 3 959 66.6 4 913 67.4<br />
Total equity and liabilities 5 946 100.0 7 285 100.0<br />
1 Includes short-term deposits of CHF 0 million (2007: CHF 125 million)
Consolidated income statements (unaudited)<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
11<br />
Full Year Fourth Quarter<br />
2008 2007 2008 2007<br />
CHF mn % CHF mn % CHF mn % CHF mn %<br />
Sales 8 071 100.0 8 533 100.0 1 744 100.0 2 086 100.0<br />
Costs of goods sold –5 757 71.3 –6 045 70.8 –1 304 74.8 –1 506 72.2<br />
Gross profit 2 314 28.7 2 488 29.2 440 25.2 580 27.8<br />
Marketing and distribution –1 216 15.1 –1 384 16.2 –288 16.5 –337 16.2<br />
administration and general overhead costs –421 5.2 –391 4.5 –74 4.2 –84 4.0<br />
research and development –184 2.3 –211 2.5 –45 2.6 –53 2.6<br />
Income from associates 37 0.5 37 0.4 9 0.5 16 0.8<br />
Gain from the disposal of activities not qualifying<br />
as discontinued operations 20 0.2 1 0.0 18 1.0 –2 0.1<br />
restructuring and impairment –321 4.0 –262 3.1 –208 11.9 –113 5.4<br />
Operating income / loss 229 2.8 278 3.3 –148 8.5 7 0.3<br />
Finance income 17 0.2 31 0.3 2 0.1 8 0.4<br />
Finance costs 1 –155 1.9 –102 1.2 –42 2.4 –17 0.8<br />
Income / loss before taxes 91 1.1 207 2.4 –188 10.8 –2 0.1<br />
taxes –119 1.4 –99 1.1 –11 0.6 –19 0.9<br />
Net loss / income from continuing operations –28 0.3 108 1.3 –199 11.4 –21 1.0<br />
Discontinued operations:<br />
loss from discontinued operations –9 –103 –8 4<br />
Net loss / income –37 5 –207 –17<br />
Attributable to:<br />
Shareholders of <strong>Clariant</strong> ltd –45 –2 –207 –19<br />
Minority interests 8 7 0 2<br />
Net loss / income –37 0.5 5 0.1 –207 11.9 –17 0.8<br />
Basic earnings per share attributable<br />
to the shareholders of <strong>Clariant</strong> Ltd (CHF/share):<br />
Continuing operations –0.16 0.44 –0.88 –0.10<br />
Discontinued operations –0.04 –0.45 –0.04 0.02<br />
Total –0.20 –0.01 –0.92 –0.08<br />
Diluted earnings per share attributable<br />
to the shareholders of <strong>Clariant</strong> Ltd (CHF/share):<br />
Continuing operations –0.16 0.44 –0.87 –0.10<br />
Discontinued operations –0.04 –0.45 –0.04 0.02<br />
Total –0.20 –0.01 –0.91 –0.08<br />
1 Currency impact ytD 2008 of CHF -53 mn ytD 2007 of CHF +23 mn.
Consolidated statements of cash flows (unaudited)<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
12<br />
Full Year Fourth Quarter<br />
CHF mn 2008 2007 2008 2007<br />
Net loss / income –37 5 –207 –17<br />
Adjustment for:<br />
Depreciation of property, plant and equipment (ppe) 244 264 60 68<br />
Impairment 209 84 188 11<br />
amortization of intangible assets 9 9 2 4<br />
Impairment of working capital 70 53 18 15<br />
Income from associates –37 –37 –9 –16<br />
tax expense 119 99 11 18<br />
Net <strong>financial</strong> income and costs 85 94 22 21<br />
Gain from the disposal of activities not qualifying<br />
as discontinued operations –20 –1 –19 2<br />
loss on disposal of discontinued operations 9 70 10 –4<br />
other non-cash items 50 –20 36 –18<br />
Total reversal of non-cash items 738 615 319 101<br />
Dividends received from associates 34 30 0 1<br />
Interest paid –98 –86 –12 –2<br />
Interest received 15 29 3 6<br />
Income taxes paid –109 –88 –14 –23<br />
Cash flow before changes in working capital and provisions 543 505 89 66<br />
Changes in inventories –136 –39 142 –19<br />
Changes in trade receivables 153 20 245 71<br />
Changes in trade payables –106 76 –94 76<br />
Changes in other current assets and liabilities –43 –69 –100 5<br />
Changes in provisions –20 47 –65 21<br />
Cash flow from operating activities 391 540 217 220<br />
Investments in ppe –270 –312 –93 –101<br />
Investments in <strong>financial</strong> assets and associates –17 –15 5 –7<br />
Investments in other intangible assets –21 –8 –10 –7<br />
Changes in current <strong>financial</strong> assets 135 –116 9 –132<br />
Sale of ppe and intangible assets 17 18 7 3<br />
acquisition of companies, businesses and participations –42 –8 –1 –8<br />
proceeds from the disposal of discontinued operations –14 25 0 –12<br />
proceeds from the disposal of subsidiaries and associates 31 23 29 1<br />
Cash flow from investing activities –181 –393 –54 –263<br />
reduction of share capital to shareholders of <strong>Clariant</strong> ltd –57 –57 0 0<br />
treasury share transactions –6 –8 –6 0<br />
proceeds from <strong>financial</strong> debts 289 308 8 –14<br />
repayments of <strong>financial</strong> debts –552 –317 –58 –29<br />
Dividends paid to minority shareholders –5 –9 0 0<br />
Cash flow from financing activities –331 –83 –56 –43<br />
Currency translation effect on cash and cash equivalents –32 2 –21 –4<br />
Net change in cash and cash equivalents –153 66 86 –90<br />
Cash and cash equivalents at the beginning of the period 509 443 270 599<br />
Cash and cash equivalents at the end of the period 356 509 356 509
Consolidated statements of recognized income and expense (unaudited)<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
13<br />
Full Year<br />
2008 2007<br />
CHF mn CHF mn<br />
Net investment hedge 111 –31<br />
Currency translation differences –401 26<br />
tax on items taken directly to or transferred from equity 0 –3<br />
Net income recognized directly in equity –290 –8<br />
Net loss / income –37 5<br />
Total recognized income and expense for the period –327 –3<br />
Attributable to:<br />
Shareholders of <strong>Clariant</strong> ltd –323 –11<br />
Minority interests –4 8<br />
this statement shows only changes in equity other than those arising from capital transactions with owners and distributions to owners.
1. Divisional Figures<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
Full Year Sales to 3rd parties EBITDA before exceptionals EBITDA<br />
CHF mn 2008 2007 % CHF % LC 2008 2007 % CHF % LC 2008 2007 % CHF % LC<br />
textile, leather, paper 2 020 2 332 –13 –6 152 217 –30 –22 117 167 –30 –22<br />
pigments & additives 1 948 2 076 –6 0 293 278 5 12 287 180 59 69<br />
Masterbatches 1 278 1 380 –7 –1 122 153 –20 –14 111 136 –18 –12<br />
Functional Chemicals 2 825 2 745 3 9 316 262 21 28 305 261 17 25<br />
Divisions Total 8 071 8 533 883 910 820 744<br />
Corporate 0 0 –100 –98 –129 –116<br />
Total continuing 8 071 8 533 –5 1 783 812 –4 3 691 628 10 17<br />
Operating income before exceptionals Operating income Systematic depreciation of PPE<br />
CHF mn 2008 2007 % CHF % LC 2008 2007 % CHF % LC 2008 2007<br />
textile, leather, paper 87 145 –40 –30 –131 40 – – 65 72<br />
pigments & additives 216 192 13 20 198 77 157 172 75 84<br />
Masterbatches 89 124 –28 –22 76 102 –25 –19 32 29<br />
Functional Chemicals 249 194 28 37 236 194 22 30 66 68<br />
Divisions Total 641 655 379 413 238 253<br />
Corporate –111 –116 –150 –135 6 11<br />
Total continuing 530 539 –2 7 229 278 –18 –6 244 264<br />
Fourth Quarter Sales to 3rd parties EBITDA before exceptionals EBITDA<br />
CHF mn 2008 2007 % CHF % LC 2008 2007 % CHF % LC 2008 2007 % CHF % LC<br />
textile, leather, paper 429 553 –22 –13 11 52 –79 –73 9 43 –79 –73<br />
pigments & additives 370 490 –24 –20 46 67 –31 –27 52 –12 – –<br />
Masterbatches 258 315 –18 –11 8 32 –75 –67 8 30 –73 –69<br />
Functional Chemicals 687 728 –6 3 80 78 3 12 78 77 1 11<br />
Divisions Total 1 744 2 086 145 229 147 138<br />
Corporate 0 0 –41 –35 –45 –48<br />
Total continuing 1 744 2 086 –16 –9 104 194 –46 40 102 90 13 24<br />
Operating income before exceptionals Operating income Systematic depreciation of PPE<br />
CHF mn 2008 2007 % CHF % LC 2008 2007 % CHF % LC 2008 2007<br />
textile, leather, paper –5 34 – – –189 25 – – 17 18<br />
pigments & additives 27 41 –34 –30 31 –48 – – 18 25<br />
Masterbatches 0 28 – –96 0 25 – –98 8 4<br />
Functional Chemicals 64 61 5 14 59 60 –2 7 16 18<br />
Divisions Total 86 164 –99 62 59 65<br />
Corporate –44 –42 –49 –55 1 3<br />
Total continuing 42 122 –66 –60 –148 7 – – 60 68<br />
14
2. Divisional Margins<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
Full Year Sales to 3rd parties EBITDA before EBITDA<br />
exceptionals<br />
in % 2008 2007 2008 2007 2008 2007<br />
textile, leather, paper 25.1 27.3 7.5 9.3 5.8 7.2<br />
pigments & additives 24.1 24.3 15.0 13.4 14.7 8.7<br />
Masterbatches 15.8 16.2 9.5 11.1 8.7 9.9<br />
Functional Chemicals 35.0 32.2 11.2 9.5 10.8 9.5<br />
Total continuing 100.0 100.0 9.7 9.5 8.6 7.4<br />
Operating income Operating income<br />
b. exceptionals<br />
in % 2008 2007 2008 2007<br />
textile, leather, paper 4.3 6.2 –6.5 1.7<br />
pigments & additives 11.1 9.2 10.2 3.7<br />
Masterbatches 7.0 9.0 5.9 7.4<br />
Functional Chemicals 8.8 7.1 8.4 7.1<br />
Total continuing 6.6 6.3 2.8 3.3<br />
Fourth Quarter Sales to 3rd parties EBITDA before EBITDA<br />
exceptionals<br />
in % 2008 2007 2008 2007 2008 2007<br />
textile, leather, paper 24.6 26.5 2.6 9.4 2.1 7.8<br />
pigments & additives 21.2 23.5 12.4 13.7 14.1 –2.4<br />
Masterbatches 14.8 15.1 3.1 10.2 3.1 9.5<br />
Functional Chemicals 39.4 34.9 11.6 10.7 11.4 10.6<br />
Total continuing 100.0 100.0 6.0 9.3 5.8 4.3<br />
Operating income Operating income<br />
b. exceptionals<br />
in % 2008 2007 2008 2007<br />
textile, leather, paper –1.2 6.1 –44.1 4.5<br />
pigments & additives 7.3 8.4 8.4 –9.8<br />
Masterbatches 0.0 8.9 0.0 7.9<br />
Functional Chemicals 9.3 8.4 8.6 8.2<br />
Total continuing 2.4 5.8 –8.5 0.3<br />
15
3. Regional developments<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
sales Full Year Fourth Quarter<br />
CHF mn 2008 % of sales 2007 % of sales CHF % LC % 2008 % of sales 2007 % of sales CHF % LC %<br />
europe 3 861 47.9 4 155 48.7 –7 –3 771 44.2 1 000 47.9 –23 –14<br />
of which Germany 1 202 1 252 –4 –1 235 312 –25 –18<br />
of which Switzerland 141 147 –4 –1 29 36 –19 –15<br />
americas 2 255 27.9 2 364 27.7 –5 4 540 31.0 588 28.2 –8 1<br />
of which USA 900 995 –10 1 211 232 –9 –10<br />
of which brazil 583 589 –1 2 130 154 –16 5<br />
asia / australia / africa 1 955 24.2 2 014 23.6 –3 7 433 24.8 498 23.9 –13 –8<br />
of which China 366 382 –4 2 67 96 –30 –33<br />
Total continuing operations 8 071 100.0 8 533 100.0 –5 1 1 744 100.0 2 086 100.0 –16 –9<br />
Discontinued operations 0 82 0 1<br />
16
4. Foreign Exchange Rates<br />
quarterly report<br />
CONDENSED FINANCIAL STATEMENTS<br />
(UNAUDITED)<br />
Rates used to translate the consolidated 31.12.2008 31.12.2007 Change %<br />
balance sheets (closing rate)<br />
1 uSD 1.06 1.13 –6<br />
1 eur 1.49 1.66 –10<br />
1 GBp 1.53 2.25 –32<br />
100 Jpy 1.17 1.01 16<br />
17<br />
Full Year<br />
Average sales-weighted rates used to translate the income 2008 2007 Change %<br />
statements and consolidated statements of cash flows<br />
1 uSD 1.08 1.20 –10<br />
1 eur 1.59 1.64 –3<br />
1 GBp 2.02 2.40 –16<br />
100 Jpy 1.05 1.02 3<br />
5. Condensed Earnings Per Share Data<br />
Full Year<br />
CHF mn 2008 2007<br />
Number of shares outstanding at 31.12.2008 230 160 000 230 160 000<br />
and 31.12.2007 respectively<br />
Weighted average, 226 532 736 227 153 836<br />
number of shares outstanding<br />
Weighted average, diluted 227 643 237 228 367 397<br />
number of shares outstanding<br />
Basic earnings per share attributable<br />
to the shareholders of <strong>Clariant</strong> ltd (Chf/share):<br />
Continuing operations –0.16 0.44<br />
Discontinued operations –0.04 –0.45<br />
Total –0.20 –0.01<br />
diluted earnings per share attributable<br />
to the shareholders of <strong>Clariant</strong> ltd (Chf/share):<br />
Continuing operations –0.16 0.44<br />
Discontinued operations –0.04 –0.45<br />
Total –0.20 –0.01
<strong>Clariant</strong> – exaCtly your Chemistry.<br />
<strong>Clariant</strong> is a global leader in the field of specialty chemicals. Strong<br />
business relationships, commitment to outstanding service and wideranging<br />
application know-how make <strong>Clariant</strong> a preferred partner for its<br />
customers.<br />
<strong>Clariant</strong>, which is represented on five continents with over 100 group<br />
companies, employs about 20,000 people. Headquartered in Muttenz<br />
near Basel, it generated sales of around CHF 8 billion in 2008.<br />
<strong>Clariant</strong>’s businesses are organized in four divisions: textile, leather &<br />
paper Chemicals, pigments & additives, Functional Chemicals and Masterbatches.<br />
Calendar of Corporate Events<br />
april 2, 2009 annual General Meeting<br />
May 6, 2009 First quarter 2009 <strong>results</strong><br />
July 30, 2009 First Half 2009 <strong>results</strong><br />
November 4, 2009 Nine Month 2009 <strong>results</strong><br />
Your <strong>Clariant</strong> Contacts<br />
Investor Relations Fax +41 61 469 67 67<br />
ulrich Steiner tel. +41 61 469 67 45<br />
Jaideep pandya tel. +41 61 469 67 49<br />
Media Relations Fax +41 61 469 69 99<br />
arnd Wagner tel. +41 61 469 61 58<br />
18<br />
<strong>Clariant</strong> is committed to sustainable growth springing from its own<br />
innovative strength. <strong>Clariant</strong>’s innovative products play a key role in its<br />
customers’ manufacturing and treatment processes or else add value to<br />
their end products. the company’s success is based on the know-how<br />
of its people and their ability to identify new customer needs at an<br />
early stage and to work together with customers to develop innovative,<br />
efficient solutions.<br />
www.clariant.com<br />
Disclaimer<br />
this document contains certain statements that are neither reported <strong>financial</strong> <strong>results</strong> nor other historical information. this presentation also includes<br />
forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future <strong>results</strong> may differ materially<br />
from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond <strong>Clariant</strong>’s ability to<br />
control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental<br />
regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s<br />
ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet<br />
its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends<br />
or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. readers are cautioned not to<br />
place undue reliance on these forward-looking statements, which speak only as of the date of this document. <strong>Clariant</strong> does not undertake any obligation<br />
to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.